Talfirastide: all 31 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Cardiovascular Effects of Angiotensin-(1-7) in Obesity HypertensionRecruitingNCT06482853Early Phase 1
- Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain InjuryRecruitingNCT06282965Phase 1/2
- Phase 2 Study of TXA127 in Post-ischemic Stroke PatientsRecruitingNCT06135103Phase 2
- TXA127 in Non-Ambulant Patients With DMD CardiomyopathyRecruitingNCT06013839Phase 2
- Metabolic Effects of Angiotensin-(1-7)RecruitingNCT02646475Phase 1
- Novel Experimental COVID-19 Therapies Affecting Host ResponseCompletedNCT04924660Phase 2/3Results posted
- TXA127 for the Treatment of Severe COVID-19CompletedNCT04401423Phase 2Results posted
- Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryCompletedNCT01553539Phase 2Results posted
- Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal CancerCompletedNCT00771810Phase 2Results posted
- Biomarker Study: Heart Failure Patients at RiskStatus unknownNCT05336175Phase 1/2
- Angiotensin-(1-7) Cardiovascular Effects in AgingTerminatedNCT05301192Early Phase 1
- Use of Angiotensin-(1-7) in COVID-19CompletedNCT04633772Phase 1/2
- Angiotensin 1-7 as a Therapy in the Treatment of COVID-19Status unknownNCT04605887Phase 2
- Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized PatientsWithdrawnNCT04570501Phase 1/2
- Angiotensin-(1,7) Treatment in COVID-19: the ATCO TrialStatus unknownNCT04332666Phase 2/3
- Angiotensin-(1-7) and Energy Expenditure in Human ObesityCompletedNCT03777215Early Phase 1
- Angiotensin 1-7 in Obesity HypertensionTerminatedNCT03604289Early Phase 1
- Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABGTerminatedNCT03252093Phase 2
- Angiotensin-(1-7) in Peripheral Arterial DiseaseTerminatedNCT03240068Early Phase 1
- Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure PatientsSuspendedNCT03159988Phase 2
- Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive SubjectsStatus unknownNCT03001271Early Phase 1
- Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic FailureTerminatedNCT02591173Early Phase 1
- Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationWithdrawnNCT01882387Phase 2
- Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood TransplantationWithdrawnNCT01882374Phase 2
- Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood TransplantationWithdrawnNCT01554254Phase 2
- Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)CompletedNCT01543971Phase 1
- Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and ThrombocytopeniaTerminatedNCT01362036Phase 1
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood TransplantationTerminatedNCT01300611Phase 1
- Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma PatientsTerminatedNCT01121120Phase 2
- Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART TherapyTerminatedNCT00757250Phase 1
- Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00471562Phase 1